CN113667653A - Transdermal full-absorption type anti-aging nano functional mask based on superoxide dismutase - Google Patents
Transdermal full-absorption type anti-aging nano functional mask based on superoxide dismutase Download PDFInfo
- Publication number
- CN113667653A CN113667653A CN202110993092.8A CN202110993092A CN113667653A CN 113667653 A CN113667653 A CN 113667653A CN 202110993092 A CN202110993092 A CN 202110993092A CN 113667653 A CN113667653 A CN 113667653A
- Authority
- CN
- China
- Prior art keywords
- sod
- aging
- mutated
- sod enzyme
- superoxide dismutase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 11
- 102000019197 Superoxide Dismutase Human genes 0.000 title abstract description 20
- 108010012715 Superoxide dismutase Proteins 0.000 title abstract description 20
- 238000010521 absorption reaction Methods 0.000 title abstract description 4
- 102000004190 Enzymes Human genes 0.000 claims description 31
- 108090000790 Enzymes Proteins 0.000 claims description 31
- 229910052802 copper Inorganic materials 0.000 claims description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 239000002537 cosmetic Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004202 carbamide Substances 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 229920002674 hyaluronan Polymers 0.000 claims description 3
- 229960003160 hyaluronic acid Drugs 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims 2
- 229940088594 vitamin Drugs 0.000 claims 2
- 239000011782 vitamin Substances 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 238000002791 soaking Methods 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 230000009759 skin aging Effects 0.000 abstract description 4
- 230000037303 wrinkles Effects 0.000 abstract 1
- 102220489765 Cofilin-1_H47A_mutation Human genes 0.000 description 13
- 238000012360 testing method Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 230000001815 facial effect Effects 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 102220484419 Myb/SANT-like DNA-binding domain-containing protein 1_S39G_mutation Human genes 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- MQIGTEQXYCRLGK-BQBZGAKWSA-N Ala-Gly-Pro Chemical compound C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O MQIGTEQXYCRLGK-BQBZGAKWSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- -1 lipid peroxides Chemical class 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- NWVVKQZOVSTDBQ-CIUDSAMLSA-N Ala-Glu-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NWVVKQZOVSTDBQ-CIUDSAMLSA-N 0.000 description 1
- NHLAEBFGWPXFGI-WHFBIAKZSA-N Ala-Gly-Asn Chemical compound C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N NHLAEBFGWPXFGI-WHFBIAKZSA-N 0.000 description 1
- WMYJZJRILUVVRG-WDSKDSINSA-N Ala-Gly-Gln Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O WMYJZJRILUVVRG-WDSKDSINSA-N 0.000 description 1
- FFZJHQODAYHGPO-KZVJFYERSA-N Ala-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N FFZJHQODAYHGPO-KZVJFYERSA-N 0.000 description 1
- MSWSRLGNLKHDEI-ACZMJKKPSA-N Ala-Ser-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O MSWSRLGNLKHDEI-ACZMJKKPSA-N 0.000 description 1
- 101000836247 Aquifex pyrophilus Superoxide dismutase [Fe] Proteins 0.000 description 1
- OQPAZKMGCWPERI-GUBZILKMSA-N Arg-Ser-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O OQPAZKMGCWPERI-GUBZILKMSA-N 0.000 description 1
- OOWSBIOUKIUWLO-RCOVLWMOSA-N Asn-Gly-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O OOWSBIOUKIUWLO-RCOVLWMOSA-N 0.000 description 1
- LMIWYCWRJVMAIQ-NHCYSSNCSA-N Asn-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N LMIWYCWRJVMAIQ-NHCYSSNCSA-N 0.000 description 1
- SBHUBSDEZQFJHJ-CIUDSAMLSA-N Asp-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O SBHUBSDEZQFJHJ-CIUDSAMLSA-N 0.000 description 1
- YDJVIBMKAMQPPP-LAEOZQHASA-N Asp-Glu-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O YDJVIBMKAMQPPP-LAEOZQHASA-N 0.000 description 1
- RNAQPBOOJRDICC-BPUTZDHNSA-N Asp-Met-Trp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(=O)O)N RNAQPBOOJRDICC-BPUTZDHNSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- LPBUBIHAVKXUOT-FXQIFTODSA-N Cys-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CS)N LPBUBIHAVKXUOT-FXQIFTODSA-N 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- KQDMENMTYNBWMR-WHFBIAKZSA-N Gly-Asp-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O KQDMENMTYNBWMR-WHFBIAKZSA-N 0.000 description 1
- LHYJCVCQPWRMKZ-WEDXCCLWSA-N Gly-Leu-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LHYJCVCQPWRMKZ-WEDXCCLWSA-N 0.000 description 1
- WMGHDYWNHNLGBV-ONGXEEELSA-N Gly-Phe-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 WMGHDYWNHNLGBV-ONGXEEELSA-N 0.000 description 1
- GLACUWHUYFBSPJ-FJXKBIBVSA-N Gly-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN GLACUWHUYFBSPJ-FJXKBIBVSA-N 0.000 description 1
- ZVXMEWXHFBYJPI-LSJOCFKGSA-N Gly-Val-Ile Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZVXMEWXHFBYJPI-LSJOCFKGSA-N 0.000 description 1
- WEIYKCOEVBUJQC-JYJNAYRXSA-N His-Glu-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC2=CN=CN2)N WEIYKCOEVBUJQC-JYJNAYRXSA-N 0.000 description 1
- CGAMSLMBYJHMDY-ONGXEEELSA-N His-Val-Gly Chemical compound CC(C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC1=CN=CN1)N CGAMSLMBYJHMDY-ONGXEEELSA-N 0.000 description 1
- 208000002979 Influenza in Birds Diseases 0.000 description 1
- GPJGFSFYBJGYRX-YUMQZZPRSA-N Lys-Gly-Asp Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O GPJGFSFYBJGYRX-YUMQZZPRSA-N 0.000 description 1
- FHIAJWBDZVHLAH-YUMQZZPRSA-N Lys-Gly-Ser Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FHIAJWBDZVHLAH-YUMQZZPRSA-N 0.000 description 1
- WVJNGSFKBKOKRV-AJNGGQMLSA-N Lys-Leu-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WVJNGSFKBKOKRV-AJNGGQMLSA-N 0.000 description 1
- WGXOKDLDIWSOCV-MELADBBJSA-N Phe-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O WGXOKDLDIWSOCV-MELADBBJSA-N 0.000 description 1
- CDQCFGOQNYOICK-IHRRRGAJSA-N Phe-Glu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 CDQCFGOQNYOICK-IHRRRGAJSA-N 0.000 description 1
- OQTDZEJJWWAGJT-KKUMJFAQSA-N Phe-Lys-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O OQTDZEJJWWAGJT-KKUMJFAQSA-N 0.000 description 1
- PEFJUUYFEGBXFA-BZSNNMDCSA-N Phe-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 PEFJUUYFEGBXFA-BZSNNMDCSA-N 0.000 description 1
- ALJGSKMBIUEJOB-FXQIFTODSA-N Pro-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@@H]1CCCN1 ALJGSKMBIUEJOB-FXQIFTODSA-N 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- UFKPDBLKLOBMRH-XHNCKOQMSA-N Ser-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N)C(=O)O UFKPDBLKLOBMRH-XHNCKOQMSA-N 0.000 description 1
- HEUVHBXOVZONPU-BJDJZHNGSA-N Ser-Leu-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HEUVHBXOVZONPU-BJDJZHNGSA-N 0.000 description 1
- UBRMZSHOOIVJPW-SRVKXCTJSA-N Ser-Leu-Lys Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O UBRMZSHOOIVJPW-SRVKXCTJSA-N 0.000 description 1
- JLKWJWPDXPKKHI-FXQIFTODSA-N Ser-Pro-Asn Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CC(=O)N)C(=O)O JLKWJWPDXPKKHI-FXQIFTODSA-N 0.000 description 1
- TZKPNGDGUVREEB-FOHZUACHSA-N Thr-Asn-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O TZKPNGDGUVREEB-FOHZUACHSA-N 0.000 description 1
- YBXMGKCLOPDEKA-NUMRIWBASA-N Thr-Asp-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YBXMGKCLOPDEKA-NUMRIWBASA-N 0.000 description 1
- UDQBCBUXAQIZAK-GLLZPBPUSA-N Thr-Glu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UDQBCBUXAQIZAK-GLLZPBPUSA-N 0.000 description 1
- XFTYVCHLARBHBQ-FOHZUACHSA-N Thr-Gly-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O XFTYVCHLARBHBQ-FOHZUACHSA-N 0.000 description 1
- FDALPRWYVKJCLL-PMVVWTBXSA-N Thr-His-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)NCC(O)=O FDALPRWYVKJCLL-PMVVWTBXSA-N 0.000 description 1
- LECUEEHKUFYOOV-ZJDVBMNYSA-N Thr-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)[C@@H](C)O LECUEEHKUFYOOV-ZJDVBMNYSA-N 0.000 description 1
- IMXAAEFAIBRCQF-SIUGBPQLSA-N Tyr-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N IMXAAEFAIBRCQF-SIUGBPQLSA-N 0.000 description 1
- KNYHAWKHFQRYOX-PYJNHQTQSA-N Val-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N KNYHAWKHFQRYOX-PYJNHQTQSA-N 0.000 description 1
- AEFJNECXZCODJM-UWVGGRQHSA-N Val-Val-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)NCC([O-])=O AEFJNECXZCODJM-UWVGGRQHSA-N 0.000 description 1
- AOILQMZPNLUXCM-AVGNSLFASA-N Val-Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN AOILQMZPNLUXCM-AVGNSLFASA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- JYPCXBJRLBHWME-UHFFFAOYSA-N glycyl-L-prolyl-L-arginine Natural products NCC(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O JYPCXBJRLBHWME-UHFFFAOYSA-N 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
- C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
- C12Y115/01001—Superoxide dismutase (1.15.1.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention provides a novel superoxide dismutase mutant, which shows the functions of improving skin aging and reducing wrinkles and has wide application prospect. Further, the invention also provides a transdermal full-absorption type anti-aging nano functional mask containing the mutant.
Description
Technical Field
The invention belongs to the field of biological enzymes, and particularly relates to mutated superoxide dismutase and a transdermal full-absorption type anti-aging nano functional mask based on the superoxide dismutase.
Background
Two major causes of skin aging are due to sunlight irradiation and the invasion of active oxygen. The active oxygen removes foreign substances by decomposing the foreign substances in the process of removing the foreign substances introduced into the body. However, if too much active oxygen is generated for various reasons while playing a positive role, it not only attacks the own cell tissue but also combines with unsaturated fatty acids in the body to form lipid peroxides. In particular, it binds to proteins and lipids in the skin to form oxides, which causes skin aging, and it acts strongly on the oxidation process of melanin, causing pigmentation.
Superoxide Dismutase (SOD) is an antioxidant metalloenzyme existing in organisms, can catalyze Superoxide anion free radical disproportionation to generate oxygen and hydrogen peroxide, and plays a vital role in the balance of oxidation and antioxidation of the organisms. Generally, SOD can be classified into Cu, Zn-SOD, Mn-SOD and Fe-SOD according to the metal prosthetic group contained in SOD. The supplement of the exogenous SOD has the functions of delaying skin aging, resisting oxidation and removing color spots, and can be widely added into various cosmetics or skin care products.
Since the eighties of the last century in China, the application research of SOD mainly focuses on the extraction and purification of animal and plant SOD, most of domestic SOD products are prepared from animal blood, but the product yield is limited due to the limited raw materials, the sanitary safety and the like, particularly, with the occasional reports of malignant infectious diseases such as mad cow disease, avian influenza, foot and mouth disease and the like all over the world, the risk of animal-derived blood products is increased, the product cost is increased due to the increased purity requirement, particularly, due to the influence of mad cow disease, the European Union stipulates that after the use of bovine blood SOD as a food additive is forbidden from 1 month in 1997, the use of genetic engineering is an effective way of widely opening SOD enzyme sources, reducing the cost and obtaining SOD with natural activity. However, SOD enzymes have problems of low yield of genetic engineering, unstable activity, etc., and it is necessary to increase their stability to a wider range of temperatures for easy transportation when applied to cosmetics, so that it is necessary to develop an SOD enzyme capable of overcoming the above disadvantages.
Disclosure of Invention
In order to solve the above technical problems, the present application provides, in a first aspect, a mutated Cu, Zn-SOD enzyme. More specifically, the amino acid sequence of the mutant Cu, Zn-SOD enzyme is shown in SEQ ID NO. 1.
In a second aspect of the present application, there is provided a use of a mutated Cu, Zn-SOD enzyme in preparing an anti-aging cosmetic, preferably, the cosmetic is a essence or a mask, and more preferably, the essence comprises the following components by mass:
2-5% of mutated Cu, Zn-SOD enzyme, 5-8% of glycerol, 0.01-2% of hyaluronic acid, 0.01-2% of levorotatory vitamin C, 2-5% of vitamin E, 1-2% of urea, 0.5-2% of propylene glycol and the balance of deionized water.
In a third aspect of the application, an anti-aging facial mask containing the mutated Cu, Zn-SOD enzyme is provided, and the preparation method of the facial mask is to soak a facial mask material with the essence or add the essence into the facial mask material. More preferably, the facial mask is a nano facial mask.
Compared with the prior art, the invention has the following advantages and beneficial effects:
1) according to the invention, amino acid mutation is carried out on Cu and Zn-SOD enzymes (NP-012638.1) of Saccharomyces cerevisiae (Saccharomyces cerevisiae), so that the H47A and G86W double-mutation Cu and Zn-SOD enzymes are obtained, and under the condition of activity maintenance, the thermal stability is obviously improved, and the application value and the economic value are wide;
2) the mutant Cu, Zn-SOD enzyme is produced by fermentation through a genetic engineering technology and is prepared into skin care products such as essence, facial masks and the like, and the products can restore the elasticity of the skin and have obvious anti-aging effect.
Drawings
FIG. 1 comparison of enzyme activities of respective mutants before and after heat treatment
Detailed Description
Example 1: thermostability of mutant enzymes
Cu and Zn-SOD enzymes (NP-012638.1) from Saccharomyces cerevisiae (Saccharomyces cerevisiae) are obtained from NCBI, and 4 key amino acid sites (S39G, H47A, G86W and H131Q) on the active site of the Cu and Zn-SOD enzymes are selected for mutation transformation research.
And (3) constructing a Cu, Zn-SOD enzyme site-directed modification mutant by using a one-step reverse PCR method, and transforming the correctly constructed site-directed mutation modification plasmid into a host cell after sequencing verification.
The single colony is separated from the correctly constructed recombinant bacteria of each mutation site (group 1: S39G + H47A, group 2: S39G + G86W, group 3: S39G + H131Q, group 4: H47A + G86W, group 5: H47A + H131Q and group 6: G86W + H131Q) by plate and streak, the single colony is picked up to be cultured in LB culture medium (Kan) for 12H, inoculated to TB fermentation culture medium (Kan) for fermentation for 26H, and fermentation supernatant, namely each mutant recombinase is taken to be subjected to heat preservation and heat treatment in water bath at the temperature of 7.0 and 60 ℃ for 15min, and the enzyme activities before and after the heat treatment are respectively detected. The original enzyme activity without mutation and without heat treatment at 60 ℃ was taken as 100% (control group). As shown in FIG. 1, the residual enzyme activity of the S39G + H47A and H47A + G86W mutants after heat treatment is higher than that of the control bacteria. The H47A + G86W mutant showed a significant increase in thermostability.
Example 2: verification of antioxidant Activity
Test samples: wild type Cu, Zn-SOD enzyme and H47A + G86W double mutation Cu, Zn-SOD enzyme are respectively mixed with ultrapure water and diluted into test solution with mass fraction of 5%.
Hydroxyl radical scavenging experiments: respectively measuring absorbance values of the mixed solutions at 536nm by using a spectrophotometric method conventional in the field, recording As, replacing a sample solution with distilled water As a blank group, recording As Ab, replacing H with distilled water2O2And measuring the absorbance value An of the damage group, and calculating the hydroxyl radical clearance of the test sample according to the following formula: hydroxyl radical clearance (%) [ (As-An)/(Ab-An)]X 100%, the average of three measurements was taken. The test results are shown in table 1.
DPPH free radical scavenging experiments: taking 3mL of 0.2mmol/L DPPH-absolute ethanol solution, adding 1mL of test sample, mixing uniformly, keeping out of the sun for 30min at room temperature, measuring the absorbance at the wavelength of 517nm, and recording the absorbance value as A1, adding 3mL of absolute ethanol solution and 1mL of test sample solution, and recording the absorbance values as A2, and adding 3mL of DPPH-absolute ethanol solution and 1mL of absolute ethanol solution, and recording the absorbance values as A3. DPPH radical clearance was calculated as follows: DPPH radical clearance (%) [1- (a1-a2)/A3] × 100%, average of three measurements. The test results are shown in table 1.
TABLE 1
The experimental results in table 1 show that the hydroxyl radical clearance and DPPH radical clearance of the H47A + G86W double-mutation Cu and Zn-SOD enzyme of the invention are improved relative to the wild type, which indicates that the mutant Cu and Zn-SOD enzyme with improved thermal stability can effectively clear away the free radicals and has the effects of oxidation resistance and aging resistance.
Example 3 mutant preparations skin elasticity and moisturization function test
The H47A + G86W double-mutation Cu, Zn-SOD enzyme is prepared into skin care essence, and the skin care essence comprises the following components in percentage by mass:
H47A + G86W double-mutation Cu, 5% of Zn-SOD enzyme, 5% of glycerol, 1.5% of hyaluronic acid, 1% of levorotatory vitamin C, 5% of vitamin E, 1% of urea, 0.5% of propylene glycol and the balance of deionized water.
The control group 1 is prepared by replacing H47A + G86W double-mutation Cu, Zn-SOD enzyme with wild-type Cu, Zn-SOD enzyme.
Control 2 was prepared without addition of Cu, Zn-SOD enzyme.
Testing the population: 60 healthy volunteers with an average age of 40 + -2 were selected, randomized into three groups of 20 individuals, each applied with the above samples earlier and later on the face, and the subjects could not apply any other cosmetic product on the experimental part during the experiment.
The test method comprises the following steps:
testing the change of the moisture content of the skin by using a moisture tester (CorneometerCM825) to evaluate the moisture retention degree of the three samples on the skin; the change in the value of the skin elasticity was measured with a skin elasticity tester (Cutomer dual MPA 580). The results are given in table 2 below (mean of three measurements):
TABLE 2
It will be apparent to those skilled in the art that various changes and modifications may be made in the present invention without departing from the spirit and scope of the invention. Thus, if such modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include such modifications and variations.
SEQUENCE LISTING
<110> Shenzhen Wen Biotech Limited
<120> mutant superoxide dismutase and application thereof in preparing anti-aging products
<130> 1
<160> 1
<170> PatentIn version 3.5
<210> 1
<211> 154
<212> PRT
<213> Artificial sequence
<400> 1
Met Val Gln Ala Val Ala Val Leu Lys Gly Asp Ala Gly Val Ser Gly
1 5 10 15
Val Val Lys Phe Glu Gln Ala Ser Glu Ser Glu Pro Thr Thr Val Ser
20 25 30
Tyr Glu Ile Ala Gly Asn Ser Pro Asn Ala Glu Arg Gly Phe Ala Ile
35 40 45
His Glu Phe Gly Asp Ala Thr Asn Gly Cys Val Ser Ala Gly Pro His
50 55 60
Phe Asn Pro Phe Lys Lys Thr His Gly Ala Pro Thr Asp Glu Val Arg
65 70 75 80
His Val Gly Asp Met Trp Asn Val Lys Thr Asp Glu Asn Gly Val Ala
85 90 95
Lys Gly Ser Phe Lys Asp Ser Leu Ile Lys Leu Ile Gly Pro Thr Ser
100 105 110
Val Val Gly Arg Ser Val Val Ile His Ala Gly Gln Asp Asp Leu Gly
115 120 125
Lys Gly Asp Thr Glu Glu Ser Leu Lys Thr Gly Asn Ala Gly Pro Arg
130 135 140
Pro Ala Cys Gly Val Ile Gly Leu Thr Asn
145 150
Claims (7)
1. A mutated Cu, Zn-SOD enzyme, the amino acid sequence of the mutated Cu, Zn-SOD enzyme is shown in SEQ ID NO. 1.
2. Use of the mutated Cu, Zn-SOD enzyme according to claim 1 for the preparation of anti-aging cosmetic.
3. The use of claim 2, wherein the cosmetic is a serum or a mask.
4. The application of claim 3, wherein the essence comprises the following components in percentage by mass:
the mutated Cu, Zn-SOD enzyme of claim 1, 2-5%, glycerol 5-8%, hyaluronic acid 0.01-2%, L-vitamin C0.01-2%, vitamin E2-5%, urea 1-2%, propylene glycol 0.5-2%, and the balance deionized water.
5. The use according to claim 3, wherein the mask is prepared by soaking the mask material with the essence of claim 4 or adding the essence to the mask material.
6. An anti-aging product, which is a serum or a mask, and the active ingredient of which comprises the mutated Cu, Zn-SOD enzyme of claim 1.
7. The anti-aging product according to claim 6, wherein the product is a nano-mask.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2021109776516 | 2021-08-24 | ||
CN202110977651 | 2021-08-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113667653A true CN113667653A (en) | 2021-11-19 |
CN113667653B CN113667653B (en) | 2024-01-05 |
Family
ID=78546736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110993092.8A Active CN113667653B (en) | 2021-08-24 | 2021-08-27 | Transdermal total-absorption anti-aging nano-functional mask based on superoxide dismutase |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113667653B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6033889A (en) * | 1997-01-16 | 2000-03-07 | Korea Institute Of Science And Technology | Gene sequence of Aquifex pyrophilus superoxide dismutase and protein expressed in Escherichia coli |
CN101512001A (en) * | 2006-07-14 | 2009-08-19 | 诺维信股份有限公司 | Methods for increasing expression of genes in a fungal cell |
CN106619175A (en) * | 2016-11-10 | 2017-05-10 | 陕西慧康生物科技有限责任公司 | Genetic recombination superoxide dismutase mask |
-
2021
- 2021-08-27 CN CN202110993092.8A patent/CN113667653B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6033889A (en) * | 1997-01-16 | 2000-03-07 | Korea Institute Of Science And Technology | Gene sequence of Aquifex pyrophilus superoxide dismutase and protein expressed in Escherichia coli |
CN101512001A (en) * | 2006-07-14 | 2009-08-19 | 诺维信股份有限公司 | Methods for increasing expression of genes in a fungal cell |
CN106619175A (en) * | 2016-11-10 | 2017-05-10 | 陕西慧康生物科技有限责任公司 | Genetic recombination superoxide dismutase mask |
Non-Patent Citations (2)
Title |
---|
GOFFEAU, A ET AL: "NP_012638.1", 《NCBI》 * |
N SHIBATA: "Presence of Cu/Zn superoxide dismutase (SOD) immunoreactivity in neuronal hyaline inclusions in spinal cords from mice carrying a transgene for Gly93Ala mutant human Cu/Zn SOD", 《ACTA NEUROPATHOL》, vol. 95, no. 2 * |
Also Published As
Publication number | Publication date |
---|---|
CN113667653B (en) | 2024-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2019189596A (en) | Application of thermus thermophilus and yeast combined fermentation product | |
CN112043621B (en) | Preservative-free polypeptide composition with anti-aging effect | |
KR101685581B1 (en) | Compositions for improving skin wrinkle or moisture comprising Orostachys japonicus and composition prepared therefrom | |
CN111603434B (en) | Composition for improving skin wrinkles and cosmetic thereof | |
KR20190056176A (en) | Cosmetic comoposition for anti-wrinkle comprising Lactobacillus plantarum culture | |
CN105420132B (en) | A kind of saccharomyces cerevisiae and its preparing the application in skin preparations for extenal use | |
WO2023125992A1 (en) | Glutathione yeast, preparation method and use of product | |
KR20170137963A (en) | A Useful Ferment Extract For Anti-inflammatory Activity And Skin Improvement That Fermented Lettuce, Inula flower And Dandelion With Lactic Acid Bacteria And Cosmetic Composition Including The Same | |
CN115054530A (en) | Skin care composition with moisturizing and anti-aging effects and preparation method thereof | |
CN113667653B (en) | Transdermal total-absorption anti-aging nano-functional mask based on superoxide dismutase | |
KR102350857B1 (en) | Cosmetic composition containing lactic acid bacteria fermentation of chrysanthemum and magnolia extracted with YU SEONG hot spring water | |
KR102443180B1 (en) | High functional cosmetic composition having natural complex extract and ample type liquid cosmetics using the same | |
KR20200054590A (en) | Composition for improving skin barrier comprising precipitation of fermented rice bran as active ingredient | |
CN113842347B (en) | Composition of black rose lucid ganoderma ferment and black rose enzymatic hydrolysate with anti-aging and whitening activities | |
CN109077971A (en) | A kind of preparation method of fermented soybean milk and its application in cosmetics | |
CN114796087A (en) | Preparation method of hypecoum maritimum stem cell extract and application of hypecoum maritimum stem cell extract in cosmetics | |
KR20190037436A (en) | Cosmetic composition including fermented water lily extract and method for manufacturing the same | |
KR20130099277A (en) | A cosmetic composition comprising hydrolysates of ecklonia cava | |
KR101289062B1 (en) | Cosmetic composition comprising growth factor and cytokine induced human placenta | |
KR20210067567A (en) | Cosmetic composition for improving skin wrinkle comprising extract of plumeria alba flower and lilium concolor var | |
KR102482157B1 (en) | Cosmetic composition comprising the mixed culture broth of lactobacilli containing sulfur amino acids for skin stress improvement | |
CN110934815A (en) | Anti-saccharification mask containing mesenchymal stem cell culture supernatant and preparation method thereof | |
CN109758388A (en) | Utilize the functional oral-cavity article constituent of vine tea | |
CN113876833B (en) | White mulberry fermented product and preparation method and application thereof | |
CN114081862B (en) | Preparation and application of Saccharomyces cerevisiae fermentation product from highland barley wine distiller's yeast in Pan-Himalaya region |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20231204 Address after: Room 1304, No. 152 Huangbian North Road, Helong Street, Baiyun District, Guangzhou City, Guangdong Province, 510000 Applicant after: Guangzhou Wanqian vermicelli Cosmetics Co.,Ltd. Address before: 518000 32b3, building 2, building 1, Dachong Business Center (phase II), No. 9678, Shennan Avenue, Dachong community, Yuehai street, Nanshan District, Shenzhen, Guangdong Applicant before: Shenzhen Buer Biotechnology Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |